Bank of New York Mellon’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q2
Sell
-928,279
Closed -$3.53M 4192
2020
Q1
$3.53M Sell
928,279
-65,380
-7% -$248K ﹤0.01% 2255
2019
Q4
$5.06M Sell
993,659
-136,434
-12% -$694K ﹤0.01% 2340
2019
Q3
$5.71M Sell
1,130,093
-41,180
-4% -$208K ﹤0.01% 2216
2019
Q2
$7.23M Buy
1,171,273
+7,574
+0.7% +$46.7K ﹤0.01% 2150
2019
Q1
$5.4M Buy
1,163,699
+6,820
+0.6% +$31.6K ﹤0.01% 2295
2018
Q4
$4.86M Sell
1,156,879
-3,663
-0.3% -$15.4K ﹤0.01% 2310
2018
Q3
$7.28M Buy
1,160,542
+97,561
+9% +$612K ﹤0.01% 2211
2018
Q2
$8.55M Buy
1,062,981
+24,073
+2% +$194K ﹤0.01% 2102
2018
Q1
$7.75M Sell
1,038,908
-1,720
-0.2% -$12.8K ﹤0.01% 2118
2017
Q4
$6.19M Sell
1,040,628
-17,976
-2% -$107K ﹤0.01% 2240
2017
Q3
$7.79M Sell
1,058,604
-13,220
-1% -$97.3K ﹤0.01% 2118
2017
Q2
$7.28M Sell
1,071,824
-26,742
-2% -$182K ﹤0.01% 2135
2017
Q1
$10.4M Buy
1,098,566
+526,905
+92% +$4.97M ﹤0.01% 1949
2016
Q4
$4.94M Buy
571,661
+34,531
+6% +$298K ﹤0.01% 2320
2016
Q3
$3.4M Sell
537,130
-21,924
-4% -$139K ﹤0.01% 2434
2016
Q2
$2.36M Buy
559,054
+2,357
+0.4% +$9.95K ﹤0.01% 2611
2016
Q1
$2.43M Buy
556,697
+1,337
+0.2% +$5.83K ﹤0.01% 2548
2015
Q4
$3.4M Sell
555,360
-83,800
-13% -$514K ﹤0.01% 2407
2015
Q3
$3.66M Buy
639,160
+105,074
+20% +$601K ﹤0.01% 2405
2015
Q2
$3.99M Buy
534,086
+58,709
+12% +$438K ﹤0.01% 2507
2015
Q1
$2.84M Sell
475,377
-3,209
-0.7% -$19.2K ﹤0.01% 2625
2014
Q4
$3.62M Buy
478,586
+110,284
+30% +$834K ﹤0.01% 2486
2014
Q3
$1.91M Buy
368,302
+39,177
+12% +$203K ﹤0.01% 2921
2014
Q2
$1.42M Sell
329,125
-30,968
-9% -$134K ﹤0.01% 3111
2014
Q1
$1.47M Buy
360,093
+57,344
+19% +$235K ﹤0.01% 3080
2013
Q4
$1.61M Sell
302,749
-25,376
-8% -$135K ﹤0.01% 3019
2013
Q3
$1.65M Buy
328,125
+52,893
+19% +$266K ﹤0.01% 2967
2013
Q2
$1.23M Buy
+275,232
New +$1.23M ﹤0.01% 3066